Patent ID: 6083989
Filing Date: 2000-07-04
Classification: A61K

Abstract:
A method for treating a patient suffering from or susceptible to an inflammatory bowel condition comprising administering to said patient in need thereof a pharmaceutical composition comprising a pharmaceutically acceptable carrier and an effective inflammatory bowel condition-treating amount of a compound selected from the group consisting of:N-cyclohexyl-.alpha.-(2-ethoxyphenyl)nitrone,N-tert-butyl-.alpha.-(3,5-di-tert-butyl-2-hydroxyphenyl)nitrone,N-isobutyl-.alpha.-phenylnitrone,N-tert-butyl-.alpha.-(4-benzyloxyphenyl)nitrone,N-cyclobutyl-.alpha.-(2-ethoxyphenyl)nitrone,N-benzyl-.alpha.-(4-acetamidophenyl)nitrone,N-cyclopentyl-.alpha.-(2-ethoxyphenyl)nitrone,N-tert-butyl-.alpha.-(1-methylindol-3-yl)nitrone,N-tert-butyl-.alpha.-(3,5 -di-tert-butyl-4-acetoxy)nitrone,spiro[cyclohexane-1,3']-6-methoxy-3,4-dihydroisoquinoline-N-oxide,N-tert-butyl-.alpha.-(4-aminosulfonylphenyl)nitrone,and pharmaceutically acceptable salts thereof.